524 Le glaucome néovasculaire - corrélations cliniques et histopathologiques

Mocanu, Carmen; Bărăscu, Doina; Crăiţoiu, Ș; Petria, C.

doi:10.1016/s0181-5512(05)73644-5

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Das IRIS-Register der American Academy of Ophthalmology berichtete in seinem Report von 2016 für NVG eine Prävalenz von 0,23 pro 100 Patienten, was einem Anteil von 1,23 % aller Glaukome entsprach [6]. Eine etwas ältere retrospektive Studie aus Europa (Rumänien) aus dem Jahr 2005 ergab für die NVG einen Anteil von 3,9 % aller Glaukome [7].…”

Section: Epidemiologieunclassified

Neovaskularisationsglaukome – Pathogenese, Diagnose, Therapie und Prophylaxe

Greslechner,

Helbig

2023

Augenheilkunde up2date

View full text Add to dashboard Cite

show abstract

Section: Epidemiologieunclassified

Neovaskularisationsglaukome – Pathogenese, Diagnose, Therapie und Prophylaxe

Greslechner,

Helbig

2023

Augenheilkunde up2date

View full text Add to dashboard Cite

show abstract

“…Approximately 75 000-113 000 people in Europe suffer with NVG [8]. In the United States (US), the overall prevalence of NVG is generally low, but still contributes to considerable morbidity and visual loss, especially among elderly patients [9].…”

Section: Prevalence and Burden Of Neovascular Glaucomamentioning

confidence: 99%

Neovascular Glaucoma: An Update

Kalogeropoulos

Moussa

Sung

et al. 2022

Klin Monbl Augenheilkd

View full text Add to dashboard Cite

Neovascular glaucoma (NVG) is a severe type of secondary glaucoma with devastating complications and generally poor visual prognosis. NVG is defined by the development of pathological neovessels over the iris and the iridocorneal angle that can block the outflow of aqueous humor, causing elevation of intraocular pressure (IOP). The pathogenesis of NVG is, in most cases, associated with ischemia of the posterior segment, which is most frequently associated with proliferative diabetic retinopathy or central retinal vein occlusion. The advanced stages of NVG are by iris and angle neovascularization, angle, and extremely high IOP, accompanied by ocular pain and poor vision. The therapeutic approach of NVG is based on the reduction of retinal ischemia by panretinal photocoagulation. Intravitreal anti-VEGF administration can contribute to the regression of neovascularization, and topical and systemic medications may be necessary for IOP control. However, if medical treatment with these agents is not enough, surgical procedures may be required to lower IOP and prevent glaucomatous optic neuropathy. Early and prompt diagnosis, with identification of the underlying etiology, can improve IOP control and final visual outcome. The aim of this study is to review current knowledge of the pathogenesis and management of NVG.

show abstract

“…The prevalence of NVG varies in different populations based on its different etiologies. NVG has been estimated to represent about 3.9% of all glaucoma cases in a European population and an estimated 75,000 to 113,000 Europeans are affected by NVG 5 . In a tertiary care population in China, 6 NVG comprised 5.8% of all glaucoma patients, whereas the prevalence of NVG in a population-based study in Eastern India was found to be 0.01% 7 .…”

Section: Introductionmentioning

confidence: 96%